Skip to main content
. 2012 Mar 26;2(2):e000361. doi: 10.1136/bmjopen-2011-000361

Table 3.

Risk factors for prevalence of disability at detection (pre-MDT stage)

OR (95% CI) OR (95% CI) OR (95% CI)
Nerves
 0–2 1.0 1.0 1.0
 3 or more 4.53 (1.54 to 13.4) 3.87 (1.30 to 11.6) 3.73 (1.24 to 11.2)
Age, years
 <35 1.0 1.0
 ≥35 2.49 (0.83 to 7.50) 2.35 (0.77 to 7.12)
Delay in treatment, months
 ≤36 1.0
 >36 2.27 (1.04 to 4.96)
Standardised for None Age Age and delay in treatment

MDT, multidrug therapy.